Ewa Wojtanowska

Ewa Wojtanowska

Auto-generated profile, based on publicly available information

Ewa Wojtanowska

Medical University of Lodz, Lodz, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
EMEwelina Młynarska
Ewelina Młynarska
EBEmilian Budny
Emilian Budny
MSMaciej Saar
Maciej Saar
EWEwa Wojtanowska
Ewa Wojtanowska
JJJustyna Jankowska
Justyna Jankowska
BFBeata Franczyk
Beata Franczyk
Chronic kidney disease (CKD) is a very prevalent and insidious disease, particularly with initially poorly manifested symptoms that progressively culminate in the manifestation of an advanced stage of the condition. The gradual impairment of kidney function, particularly decreased filtration capacity, results in the retention of uremic toxins and affects numerous molecular mechanisms within the body. The dysbiotic intestinal microbiome plays a crucial role in the accumulation of protein-bound uremic toxins such as p-cresol (pC), indoxyl sulfate (IS), and p-cresyl sulfate (p-CS) through the ongoing fermentation process. The described phenomenon leads to an elevated level of oxidative stress and inflammation, subsequently resulting in tissue damage and complications, particularly an increase in cardiovascular risk, representing the predominant cause of mortality in chronic kidney disease (CKD). Therefore, exploring methods to reduce uremic toxins is currently a pivotal therapeutic strategy aimed at reducing the risk of organ damage in patients with chronic kidney disease (CKD). This review aims to summarize recent discoveries on modifying the composition of the intestinal microbiota through the introduction of special probiotic and synbiotic supplements for CKD therapy. The potential to connect the gut microbiota with CKD opens the possibility for further extensive research in this area, which could lead to the incorporation of synbiotics and probiotics into the fundamental treatment and prevention of CKD.

23 September 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
JTJulita Tokarek
Julita Tokarek
EBEmilian Budny
Emilian Budny
MSMaciej Saar
Maciej Saar
KSKamila Stańczak
Kamila Stańczak
EWEwa Wojtanowska
Ewa Wojtanowska
BFBeata Franczyk
Beata Franczyk
Cardiovascular diseases and diabetes mellitus are currently among the diseases with the highest morbidity and mortality. The pathogenesis and development of these diseases remain strongly connected, along with inflammation playing a major role. Therefore, the treatment possibilities showing a positive impact on both of these diseases could be especially beneficial for patients. SGLT-2 inhibitors and GLP-1 receptor agonists present this dual effect. Moreover, the hostile composition of the gut microbiota could influence the progression of these conditions. In this review, the authors present the latest knowledge on and innovations in diabetes mellitus and CVD—with the focus on the molecular mechanisms and the role of the microbiota.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
ASAleksandra Suszczyńska
Aleksandra Suszczyńska
EWEwa Wojtanowska
Ewa Wojtanowska
MMMarcin Mazur
Marcin Mazur
JKJulia Kozicka
Julia Kozicka
AWAngelika Wiatr
Angelika Wiatr
NTNatalia Tomoń
Natalia Tomoń
Gingival enlargement and epulis are common reactive lesions of the oral cavity with a multifactorial aetiology. While dental plaque is considered the primary initiating factor, systemic hormonal influences play a significant modulatory role in their development and clinical expression. This narrative review aims to summarise current evidence regarding the effects of sex steroid hormones on gingival enlargement and epulis, with particular emphasis on pregnancy-associated lesions and hormonal fluctuations throughout life. A literature search was conducted using PubMed and Google Scholar, focusing on studies investigating the effects of oestrogen and progesterone on periodontal tissues. The available evidence indicates that sex hormones influence inflammatory responses, vascular function, immune activity, microbial composition, and connective tissue metabolism within the periodontium. The findings suggest that hormonal changes do not directly initiate gingival disease but act as modifying factors that increase tissue susceptibility to local irritants, particularly dental plaque. Understanding these mechanisms is essential for improving prevention and clinical management of hormonally influenced gingival conditions.

29 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JKJulia Kozicka
Julia Kozicka
MMMarcin Mazur
Marcin Mazur
EWEwa Wojtanowska
Ewa Wojtanowska
EJEwa Jachimczak
Ewa Jachimczak
PJPaulina Jaruga
Paulina Jaruga
HKHanna Klimczyk
Hanna Klimczyk
Iron deficiency, including non-anaemic iron deficiency (NAID), is a common problem among young, menstruating female athletes, requiring precise differentiation from ‘athlete’s anaemia’, which is a physiological adaptive haemodilution. The aim of this narrative review was to summaries the mechanisms, prevalence, diagnostic principles, and clinical and performance-related consequences of these disorders. Epidemiological data indicate that hypoferritinaemia (ferritin ≤30 ng/mL) affects up to 47% of young female athletes, and 23.1% develop overt anaemia according to WHO criteria. The Pathomechanism of the negative iron balance is multifactorial and includes losses through sweat, gastrointestinal micro bleeding, mechanical haemolysis, and exercise-induced increases in interleukin-6 and hepcidin, which temporarily block intestinal iron absorption and recycling. It has also been shown that aerobic training is associated with a poorer haematological profile than anaerobic training. The consequences of NAID extend beyond reduced physical performance and fatigue, also including a decrease in bone mineral density and an increased risk of stress injuries to the lower limbs. In laboratory diagnostics, haemoglobin alone has been shown to have low sensitivity, which justifies routine measurement of ferritin (with the sports threshold raised to <30–35 ng/mL), sTfR and TSAT. In summary, optimal therapeutic management should be holistic, encompassing the provision of adequate energy intake, monitoring of vitamin levels (D, B12, folic acid) and targeted, 6–8-week course of oral supplementation in confirmed cases, whilst strictly avoiding the routine administration of high doses and intravenous infusions without clear laboratory indications.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JPJulia Paczyna
Julia Paczyna
EJEwa Jachimczak
Ewa Jachimczak
EWEwa Wojtanowska
Ewa Wojtanowska
PJPaulina Jaruga
Paulina Jaruga
KGKarolina Grodkowska-Szukała
Karolina Grodkowska-Szukała
VGVanessa Gąsiorowska
Vanessa Gąsiorowska
Background and Aim: Delirium in the Intensive Care Unit (ICU) is a complex dysfunction that poses not only a clinical threat but also a massive organizational challenge, affecting the quality of care and staff well-being. This review aims to systematize knowledge on innovative strategies for delirium management, with a specific focus on mitigating nursing burnout and implementing the integrated ABCDEF bundle as an organizational protocol in light of the PADIS (2025) and ESAIC (2024) guidelines. Methodology: A narrative literature review (2015–2026) was conducted using PubMed/MEDLINE, Scopus, and the Cochrane Library, focusing on management innovations, burnout research, and non-pharmacological interventions. Results: Traditional, pharmacologically driven methods fail to yield expected results, and the growing workload drives a severe staffing crisis. The application of the integrated ABCDEF bundle (early mobilization, analgosedation optimization) as a structural innovation in daily workflow reduces delirium incidence by 50%. The routine use of antipsychotic medications neither improves patient outcomes nor relieves system burdens. Conclusion: Combating delirium requires a transformation of the organizational culture within the ICU. Implementing the "Awake and Walking ICU" concept significantly improves patient outcomes, mitigates the socio-economic impact of Post-Intensive Care Syndrome (PICS), and effectively protects nursing staff from severe occupational burnout.

22 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
PJPaulina Jaruga
Paulina Jaruga
EJEwa Jachimczak
Ewa Jachimczak
VGVanessa Gąsiorowska
Vanessa Gąsiorowska
KGKarolina Grodkowska-Szukała
Karolina Grodkowska-Szukała
JPJulia Paczyna
Julia Paczyna
NSNatalia Smyczyńska
Natalia Smyczyńska
Glioblastoma is the most common and most aggressive primary malignant tumor of the central nervous system in adults and remains associated with a very poor prognosis despite multimodal treatment. The current standard of care consists of maximal safe surgical resection followed by radiotherapy and temozolomide-based chemotherapy; however, the effectiveness of this strategy is limited by marked tumor heterogeneity, the infiltrative growth pattern, the presence of the blood–brain barrier, and the immunosuppressive tumor microenvironment. The aim of this paper is to review current standards of GBM treatment as well as emerging therapeutic strategies under development. Analysis of the available evidence indicates that novel approaches such as intraoperative 18F-FET PET, intraoperative radiotherapy, local temozolomide delivery using hydrogel-based systems, intranasal drug administration, NanoTherm® therapy, and CAR-T immunotherapy may increase treatment precision, improve local tumor control, and partially overcome the limitations of systemic therapy. However, most of these methods remain investigational or experimental, and their actual impact on overall survival requires further validation. The integration of advanced imaging, local treatment modalities, and molecularly targeted therapies appears to be the most promising direction for future GBM management.